, India's largest drugmaker on Tuesday reported 5.2% year-on-year (YoY) jump in net profit to Rs 2,166 crore for Q3FY23 led by ramp up of global specialty drug sales, along with strong…
NEW DELHI: Amid what has so far been a mixed scorecard for India Inc’s fourth quarter earnings, companies in the healthcare space are likely to report weak numbers in the last quarter due to…